Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial

This exploratory analysis, which requires confirmation in future studies, suggests that the effect of prasinezumab in slowing motor progression in PD may be sustained long-term.此项探索性分析尚需后续研究予以验证，其结果显示普拉奈珠单抗（prasinezumab）延缓帕金森病（Parkinson's Disease, PD）运动进展的作用或可长期维持。